Site # 240 — Chicago, Illinois

Site # 240 is a clinical research site located in Chicago, Illinois, United States 60640.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site # 240 has participated in 1 clinical trials.

Therapeutic areas: Antipsychotic-induced Weight Gain (AIWG).

Sponsors: Corcept Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site # 240?

Site # 240 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site # 240 conducted?

Site # 240 has 1 clinical trials on record. Their work covers Antipsychotic-induced Weight Gain (AIWG).

Is Site # 240 accredited by Crixeo Clinical Trials?

Site # 240 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site # 240?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.